Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorophytum borivilianum is a herbaceous plant native to India, widely known as safed musli. Its tuberous roots are used in traditional medicine, especially in Ayurveda, primarily as a health tonic, adaptogen, and revitalizer. The herb is traditionally recognized for its aphrodisiac, immunomodulatory, antidiabetic, and anti-inflammatory effects. Root extracts are rich in saponins, alkaloids, polysaccharides, and antioxidant compounds. It is commonly used to improve sexual dysfunction, diabetes management, infections, and general health. While used extensively in dietary supplements, robust clinical evidence for therapeutic human use is limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorophytum borivilianum.